Marginal Zone B Cell Repertoire
Marginal Zone B Cell Repertoire
批准号:
8075257
负责人:
ANN J FEENEY
金额:
$1.33万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2011-09-30
关键词:
AdultAgeAgingAnti-Bacterial AgentsAntibodiesAntibody RepertoireAppearanceAutoantigensB cell differentiationB cell repertoireB-Lymphocyte SubsetsB-LymphocytesBacteriaBlood-Borne PathogensBone MarrowBone Marrow CellsCell surfaceCellsCharacteristicsChimera organismCollaborationsDevelopmentEmployee StrikesGrantHeterogeneityImmune responseImmunoglobulin DIn VitroKineticsLifeLightLipoproteinsMature B-LymphocyteMusPathway interactionsPhenotypePolysaccharidesPopulationProteinsRecording of previous eventsSourceSpecificitySpleenStagingTestingTo autoantigenTransgenic MiceVaccine Designbasefetalin vivomicrobialmicroorganism antigennovelpathogenpreferencepublic health relevancereconstitutionresearch studyresponse
中文摘要
描述(由申请人提供):我们最近已经表明,成人MZ B细胞含有20%的缺乏N区多样性的序列,这是胎儿衍生细胞的标志。通过使用由TdT+和TdT-骨髓细胞组成的混合骨髓嵌合体,我们已经证明,我们在MZ和FO B细胞之间观察到的库差异受到基于BCR的选择这些亚群的极大影响。在这些小鼠的分析过程中,我们观察到从骨髓中的未成熟B细胞到脾脏中的成熟B细胞的所有B细胞亚群的库中的意外和显著差异。由于在骨髓嵌合体中过渡T1区室和MZ B细胞之间对N-IgH序列和λ轻链的选择性偏好的相似性,我们提出具有不同库的MZ B细胞亚群可能直接从T1过渡区室分化而不经历T2阶段。因此,我们假设MZ区室可能是由不同的子集与不同的剧目,我们将集中在这个新的假设在这个补助金。我们最近发现了一种小鼠,它只具有直接与T1细胞分化的MZ细胞亚群,为我们提供了一种独特的方法来进行本申请中提出的研究。这里提出的实验将表征我们相信已经发现的脾脏中的多个MZ前体群体和B细胞分化的新途径。我们将使用微阵列评估这些MZ和FO B细胞亚群在微生物、蛋白质、自身抗原和聚糖特异性方面的库差异。我们还将评估这些亚群和这些库如何随年龄变化,因为其中一个MZ亚群似乎具有胎儿起源。不同脾脏亚群中潜在不同和可能变化的库的信息对于可能靶向MZ B群体的疫苗设计策略以及理解生命不同阶段对血源性病原体的应答将是关键信息。公共卫生相关性:边缘带B细胞对血液传播的病原体(包括许多细菌)做出快速反应。我们提出边缘区B细胞可以根据BCR库差异、细胞表面表型和分化历史进行细分。我们将分析这些边缘区B细胞亚群对自身抗原、聚糖和细菌病原体的抗体库,并确定抗体库是否随年龄变化。不同脾脏亚群中潜在不同和可能变化的库的信息对于可能靶向MZ B群体的疫苗设计策略以及理解生命不同阶段对血源性病原体的应答将是关键信息。
英文摘要
DESCRIPTION (provided by applicant): We have recently shown that adult MZ B cells contain 20% of sequences that lack N region diversity, a hallmark of fetally-derived cells. Through the use of mixed bone marrow chimeras comprised of TdT+ and TdT- bone marrow cells, we have demonstrated that the differences in repertoire that we observed between MZ and FO B cells was greatly influenced by BCR-based selection into these subsets. During the analyses of these mice, we observed unexpected and striking differences in the repertoires of all subpopulations of B cells from immature B cells in the bone marrow through the mature B cells in the spleen. Due to the similarity in the selective preferences for N- IgH sequences and also for lambda light chains between the transitional T1 compartment and MZ B cells in the bone marrow chimeras, we propose that a subset of MZ B cells with a distinct repertoire may have directly differentiated from the T1 transitional compartment without going through the T2 stage. We thus hypothesize that the MZ compartment may be comprised of distinct subsets with distinct repertoires, and we will focus on this novel hypothesis in this grant. We have recently identified a mouse that has only the subset of MZ cells that directly differentiates from T1 cells, providing us with a unique approach to the studies proposed in this application. The experiments presented here will characterize the multiple MZ precursor populations and novel pathways of B cell differentiation in the spleen that we believe we have uncovered. We will assess the differences in the repertoires of these subsets of MZ and FO B cells with regard to microbial, protein, autoantigen and glycan specificities using microarrays. We will also assess how these subsets and these repertoires change with age, since one of the MZ subsets appears to have a fetal origin. This information of potentially different and possibly changing repertoires in different splenic subsets will be critical information for vaccine design strategies that may target MZ B populations, and for understanding the response to blood-borne pathogens at different stages of life. PUBLIC HEALTH RELEVANCE: Marginal zone B cells make rapid responses to blood-borne pathogens, including many bacteria. We propose that the marginal zone B cells can be subdivided based on BCR repertoire differences, cell surface phenotype, and differentiation history. We will analyze the antibody repertoire of these subsets of marginal zone B cells to autoantigens, glycans, and bacterial pathogens, and will determine if the repertoire changes with age. This information of potentially different and possibly changing repertoires in different splenic subsets will be critical information for vaccine design strategies that may target MZ B populations, and for understanding the response to blood-borne pathogens at different stages of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Locus contraction at the Ig kappa locus
-
批准号:9231524
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2016
-
负责人:ANN J FEENEY
-
依托单位:
Role of germline transcription in V(D)J rearrangement
-
批准号:8970153
-
项目类别:
-
资助金额:$33.16万
-
财政年份:2015
-
负责人:ANN J FEENEY
-
依托单位:
Role of germline transcription in V(D)J rearrangement
-
批准号:9096069
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2015
-
负责人:ANN J FEENEY
-
依托单位:
Genes and pathways regulated by YY1 in early and late B cell differentiation
-
批准号:8974267
-
项目类别:
-
资助金额:$9.48万
-
财政年份:2014
-
负责人:ANN J FEENEY
-
依托单位:
Novel regulatory regions within the immunoglobulin kappa locus
-
批准号:8755573
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2014
-
负责人:ANN J FEENEY
-
依托单位:
Transcriptional heterogeneity within pro-B cells
-
批准号:8569969
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2013
-
负责人:ANN J FEENEY
-
依托单位:
Transcriptional heterogeneity within pro-B cells
-
批准号:8662199
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2013
-
负责人:ANN J FEENEY
-
依托单位:
Role of Polycomb-mediated epigenetic regulation in diffuse large B cell lymphoma
-
批准号:8416315
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2012
-
负责人:ANN J FEENEY
-
依托单位:
Role of Polycomb-mediated epigenetic regulation in diffuse large B cell lymphoma
-
批准号:8258674
-
项目类别:
-
资助金额:$33.16万
-
财政年份:2012
-
负责人:ANN J FEENEY
-
依托单位:
Biological consequences of a lymphoma-associated mutation in Ezh2 in mice
-
批准号:8309668
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2012
-
负责人:ANN J FEENEY
-
依托单位:
Biological consequences of a lymphoma-associated mutation in Ezh2 in mice
-
批准号:8435331
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2012
-
负责人:ANN J FEENEY
-
依托单位:
Next generation sequence analysis of the IgH repertoire
-
批准号:8054158
-
项目类别:
-
资助金额:$33.16万
-
财政年份:2011
-
负责人:ANN J FEENEY
-
依托单位:
Next generation sequence analysis of the IgH repertoire
-
批准号:8209162
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2011
-
负责人:ANN J FEENEY
-
依托单位:
Role of CTCF and Cohesin in V(D)J Rearrangement
-
批准号:8051799
-
项目类别:
-
资助金额:$47.0万
-
财政年份:2010
-
负责人:ANN J FEENEY
-
依托单位:
Role of CTCF and Cohesin in V(D)J Rearrangement
-
批准号:8444549
-
项目类别:
-
资助金额:$44.18万
-
财政年份:2010
-
负责人:ANN J FEENEY
-
依托单位:
Role of CTCF and Cohesin in V(D)J Rearrangement
-
批准号:8636390
-
项目类别:
-
资助金额:$47.0万
-
财政年份:2010
-
负责人:ANN J FEENEY
-
依托单位:
Marginal Zone B Cell Repertoire
-
批准号:8113084
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2010
-
负责人:ANN J FEENEY
-
依托单位:
Role of CTCF and Cohesin in V(D)J Rearrangement
-
批准号:8242058
-
项目类别:
-
资助金额:$51.0万
-
财政年份:2010
-
负责人:ANN J FEENEY
-
依托单位:
Role of CTCF and Cohesin in V(D)J Rearrangement
-
批准号:8075302
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2010
-
负责人:ANN J FEENEY
-
依托单位:
Role of CTCF and Cohesin in V(D)J Rearrangement
-
批准号:7808143
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2010
-
负责人:ANN J FEENEY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: